Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-09-30FDA Approved: TIMOPTIC-XE — Supplemental Application (Bausch & Lomb Incorporated)
FDA approved a supplemental application for TIMOPTIC-XE (timolol maleate) from Bausch & Lomb, reflecting an approved update to the product's…
-
FDA approval · 2011-03-22FDA Approved: LATANOPROST — Original Application (Bausch & Lomb Incorporated)
FDA approved latanoprost as an original application generic product by Bausch & Lomb Incorporated.
-
FDA approval · 2011-03-22FDA Approved: LATANOPROST — Original Application (Sandoz Inc)
FDA approves the generic latanoprost (Sandoz) under Original Application (ANDA). The product is indicated for reduction of elevated intraocu…
-
FDA approval · 2011-03-22FDA Approved: LATANOPROST — Original Application (Somerset Therapeutics, LLC)
FDA approved the original application for latanoprost from Somerset Therapeutics, enabling a generic latanoprost ophthalmic solution for red…
-
FDA approval · 2011-03-08FDA Approved: BRINZOLAMIDE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for brinzolamide submitted by Sandoz Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-01-28FDA Approved: DORZOLAMIDE HYDROCHLORIDE — Supplemental Application (Advagen Pharma Ltd.)
FDA approved a supplemental application for dorzolamide hydrochloride from Advagen Pharma Ltd., a generic product used to treat open-angle g…
-
FDA approval · 2010-08-31FDA Approved: LUMIGAN — Original Application (Allergan, Inc.)
The FDA approved Lumigan (bimatoprost) from Allergan, Inc. as an original application for lowering intraocular pressure in adults with open-…
-
FDA approval · 2010-08-31FDA Approved: LATANOPROST — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for latanoprost filed by Mylan Pharmaceuticals, approving a generic version of latanoprost for l…
-
FDA approval · 2010-08-13FDA Approved: ALPHAGAN P — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Alphagan P (brimonidine tartrate) from Allergan, Inc., likely involving labeling changes or …
-
FDA approval · 2010-08-03FDA Approved: BRIMONIDINE TARTRATE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for brimonidine tartrate submitted by Sandoz Inc., representing a regulatory update to the product.
-
FDA approval · 2010-07-29FDA Approved: LATANOPROST — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for latanoprost submitted by Mylan Pharmaceuticals Inc.
-
FDA approval · 2010-06-18FDA Approved: COSOPT — Supplemental Application (Thea Pharma Inc.)
FDA approved a supplemental application for COSOPT (dorzolamide hydrochloride and timolol maleate) from Thea Pharma Inc., indicating approva…
-
FDA approval · 2009-11-18FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE — Original Application (Sandoz Inc)
The FDA approved a generic dorzolamide hydrochloride and timolol maleate ophthalmic solution from Sandoz for lowering intraocular pressure i…
-
FDA approval · 2009-07-14FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE — Original Application (Bausch & Lomb Incorporated)
FDA approved the generic combination dorzolamide hydrochloride and timolol maleate for reduction of intraocular pressure in patients with op…
-
FDA approval · 2009-06-25FDA Approved: DORZOLAMIDE HCL — Original Application (Bausch & Lomb Incorporated)
FDA approved the original ANDA for dorzolamide hydrochloride ophthalmic solution (Dorzolamide HCl) from Bausch & Lomb Incorporated, enabling…
-
FDA approval · 2009-04-13FDA Approved: DORZOLAMIDE HYDROCHLORIDE — Original Application (Sandoz Inc)
FDA approved Sandoz Inc's generic dorzolamide hydrochloride ophthalmic solution under an Original Application (ANDA). It is indicated for lo…
-
FDA approval · 2008-10-28FDA Approved: DORZOLAMIDE HYDROCHLORIDE — Original Application (Advagen Pharma Ltd.)
FDA approves Advagen Pharma Ltd.'s dorzolamide hydrochloride as a generic eye drop for lowering intraocular pressure in glaucoma and ocular …
-
FDA approval · 2008-10-22FDA Approved: COSOPT — Supplemental Application (Thea Pharma Inc.)
The FDA approved a supplemental application for COSOPT (dorzolamide hydrochloride and timolol maleate) submitted by Thea Pharma Inc.
-
FDA approval · 2008-06-27FDA Approved: BETAXOLOL HYDROCHLORIDE — Original Application (KVK-TECH, INC.)
FDA approves Betaxolol hydrochloride from KVK-Tech as an original ANDA product for the treatment of open-angle glaucoma and ocular hypertens…
-
FDA approval · 2008-05-08FDA Approved: BETOPTIC S — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for BETOPTIC S (betaxolol hydrochloride) from Novartis Pharmaceuticals Corporation.
-
FDA approval · 2008-04-30FDA Approved: TIMOLOL MALEATE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original ANDA for timolol maleate from Rising Pharma Holdings, Inc., confirming a generic timolol maleate product is author…
-
FDA approval · 2007-10-30FDA Approved: COMBIGAN — Original Application (Allergan, Inc.)
The FDA approved COMBIGAN, a fixed-dose combination eye drop of brimonidine tartrate and timolol maleate, under Allergan's original NDA.
-
FDA approval · 2007-06-08FDA Approved: BETOPTIC S — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for BETOPTIC S (betaxolol hydrochloride) by Novartis Pharmaceuticals Corporation, updating the p…
-
FDA approval · 2007-06-08FDA Approved: TIMOLOL GFS — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for TIMOLOL GFS (timolol maleate) from Sandoz Inc.
-
FDA approval · 2006-09-28FDA Approved: BRINZOLAMIDE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for brinzolamide filed by Sandoz Inc to update/expand labeling.